LifeMD (LFMD) Restructuring Costs (2019 - 2025)

LifeMD (LFMD) has reported Restructuring Costs for 7 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Restructuring Costs rose 6.39% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $18.9 million (up 26.2% YoY), and the FY2025 full-year result was $11.1 million, up 27.87% from the prior year.
• Restructuring Costs eased to $2.5 million in Q4 2025 per LFMD's latest filing, from $3.0 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $10.9 million in Q2 2025 and bottomed at $636787.0 in Q1 2021.
• Historically, Restructuring Costs has averaged $2.5 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Restructuring Costs plunged 35.66% in 2023, then soared 527.37% in 2024.
• Over 5 years, Restructuring Costs stood at $1.2 million in 2021, then jumped by 38.14% to $1.6 million in 2022, then grew by 0.95% to $1.7 million in 2023, then jumped by 41.31% to $2.3 million in 2024, then gained by 6.39% to $2.5 million in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered $2.5 million, $3.0 million, and $10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.